Antibiotics, Infection and the Evidence: Update 2023

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

This advanced session describes the epidemiology of common nosocomial pathogens and the optimal use of appropriate antibiotic therapy to effectively treat infection. We review current antibiotic classes and specific drugs as well as new antibiotics and those in development. In addition, we review current evidence-based guidelines for the diagnosis and treatment of serious infections including CAUTI, CLABSI, VAP, HAP/CAP, necrotizing and severe soft tissue infections and C difficile infection management.

Objectives

Explain and analyze current recommendations for the diagnosis and treatment of VAP, CAP/HAP, UTI and bloodstream infections.
Describe the prevalence of HAIs and MDROs in the acute care setting and how this influences antibiotic prescribing practices.
Choose appropriate antimicrobial therapy for at least three severe infections in the inpatient environment.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.